Updated Data Matrix Available

Market Value | Market Volume | Epidemiology | Clinical Trials | Patent Landscape | Regulatory Approvals

Cancer Diagnostics Market by Test [Biopsy Tests (Bone Marrow, Endoscopic, Needle Biopsy), Endoscopy Tests (Bronchoscopy, Colonoscopy, Colposcopy, Sigmoidoscopy), Diagnostic Imaging (CT, MRI, PET, Mammography, Ultrasound), and Detection of Cancer-Specific Tumor Biomarkers) and Applications (Organ or Cell-Specific Cancer Types – Blood, Breast, Colorectal, Kidney, Liver, Lung, Ovarian, Pancreatic, and Prostate Cancer)] and Forecast 2024-2031


Report Specifications: Market Size, Market Share, Growth Trends, Forecast, Geography

There are many different ways to diagnose cancer. Cancer diagnostic testing involves tests and procedures to confirm the presence of disease and identify the correct tumor type, location, extent and stage. The most common diagnostic tests include biopsy tests (bone marrow, endoscopic, needle biopsy), endoscopy tests (bronchoscopy, colonoscopy, colposcopy, sigmoidoscopy, etc.), diagnostic imaging (CT, MRI, PET, mammography, ultrasound, etc.), and detection of cancer-specific tumor biomarkers.  Benign tumors are slow growing tumors and do not invade into other tissues while the malignant tumors are characterized by rapid growth, invasiveness, and potential to colonize in distant organs. The rising prevalence of cancer across the globe is driving the global cancer diagnostics market, whereas higher incidences of cancer and increasing healthcare spending is expected to aid the global tissue diagnostics market.

The global cancer diagnostics market report estimates the market size ($million 2021 to 2031) for market segmentation based on testing methods and their applications (organ or cell-specific cancer types – blood, breast, colorectal, kidney, liver, lung, ovarian, pancreatic, and prostate cancer) and forecast (CAGR%, 2024 to 2031).

The global cancer diagnostics market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global cancer diagnostics market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

Major players operating in the global cancer diagnostics market and included in this report are Abbott Laboratories, Ambry Genetics, AstraZeneca, bioMerieux, Genentech, Genoptix (Novartis), and Roche Diagnostics.

DATA INCLUDED: Cancer Diagnostic Testing Market Size, Cancer Diagnostic Testing Market Share, Cancer Diagnostic Testing Market Growth Rates, Cancer Diagnostic Testing Market Trends, and Cancer Diagnostic Testing Market Forecast to 2031

Market Data:

  • Base year for estimation: 2023
  • Actual estimates/Historical data: 2021-2031
  • Forecast period: 2024-2031
  • Market representation: Revenue in $million and CAGR % from 2024 to 2031
  • Regional scope: North America, Europe, Asia Pacific, Latin America, Rest of the World (Middle East & Africa)
  • Country scope: U.S., Canada, U.K., Germany, France, Italy, Spain, Japan, China, India, South Korea, Brazil, Mexico, South Africa, South Korea, Saudi Arabia, UAE and others.
  • Report coverage: Revenue forecast, company share, competitive landscape, growth factors, and trends
  • 15% free customization scope: Any specific or custom requirements, which is not currently within the scope of the report, will be provided as a part of customization.

Qualitative Analysis:

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Key market opportunities
  • Market size
  • Growth trends
  • Porter’s five forces analysis
  • Market attractiveness analysis
  • Competitive landscape
    • Company overview
    • Financial performance
    • Product portfolio
    • Strategic insights
    • Recent developments

Quantitative Analysis:

  • Market size estimates and forecast for all segments
  • Regional market size estimated and forecast for major countries
  • Company financial performance
  • Competitive landscape: Company market share analysis

Please contact us for offers on individual or multiple report purchases.

  1. Introduction
  2. Executive Summary
    • Market Size Estimation ($million, 2021-2031)
    • Forecast Estimation ($million and CAGR%, 2024-2031)
  3. Research Methodology
  4. Market Landscape
    • Market Dynamics
      • Drivers
      • Barriers
      • Opportunities
    • Market Share Analysis
      • Companies
      • Products
    • Market Trends Analysis
      • Key success factors
      • Market Growth Rate
    • Market Attractiveness Analysis
    • Market Profitability Analysis
      • Buyer power
      • Supplier power
      • Barriers to entry
      • Threat of substitute products
      • Rivalry among firms in the industry
    • Distribution Channels
  5. Market Segmentation [refer Market Segments and Companies Tab]
    • Diagnostic Test Type
    • Indication or Infection Type
    • Technology
    • Diagnostics Application
    • Service Type
    • End User Groups
  6. Geography (Region, Country)
    • North America (U.S., Canada)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Rest of the World (Middle East & Africa)
  7. Regulatory Overview 
    • Device Classification I, II, III, IV
    • Device (FDA, EMEA) Approvals
  8. Company Profiles [refer Market Segments and Companies Tab]
    • Company Overview
    • Financial Snapshot
    • Product Portfolio
    • Business Strategies
    • Recent Developments
  9. Recommendations
  10. References

Key Questions Answered:
1. What are the factors driving and limiting this market, key success factors and challenges?
2. Which are the leading competitors in the market, their market share, profitability and key trends by product, technology, services portfolio?
3. How do markets perform between countries and regions?
4. What market segments are contributing to maximum share and greatest growth?
5. What are the product or procedure volumes by country and regions?

Actionable Insights Included:
1. Product portfolio matrix (Share vs. Growth)
2. Market attractiveness (Region vs. Growth)
3. Spot matrix (Product vs. Region)
4. Geographic distribution matrix (Share vs. Growth)

Cancer Diagnostic Testing Market

1. Diagnostic Test
1.1. Biopsy
1.1.1. Bone Marrow Biopsy
1.1.2. Endoscopic Biopsy
1.1.3. Needle Biopsy
1.2. Endoscopy
1.2.1. Bronchoscopy
1.2.2. Colonoscopy
1.2.3. Colposcopy
1.2.4. Sigmoidoscopy
1.2.5. Others
1.3. Diagnostic Imaging
1.3.1. Computed Tomography (CT) Scan
1.3.2. Magnetic Resonance Imaging (MRI) Scan
1.3.3. Mammography
1.3.4. Positron Emission Tomography (PET) Scan
1.3.5. Ultrasound
1.4. Tumor Biomarker
1.4.1. Alpha-Fetoprotein (AFP) Tests
1.4.2. Anaplastic Lymphoma Kinase (ALK) Tests
1.4.3. BRCA Tests
1.4.4. CA 125 Tests
1.4.5. CA 19-9 Tests
1.4.6. Carcinoembryonic Antigen (CEA) Tests
1.4.7. Circulating Tumor Cells (CTC) Tests
1.4.8. EGFR Mutation Tests
1.4.9. HER2 Tests
1.4.10. KRAS Mutation Tests
1.4.11. Prostate Specific Antigen Tests

2. Application (Cancer Type)
2.1. Blood Cancer
2.2. Breast Cancer
2.3. Colorectal Cancer
2.4. Kidney Cancer
2.5. Liver Cancer
2.6. Lung Cancer
2.7. Ovarian Cancer
2.8. Pancreatic Cancer
2.9. Prostate Cancer

3. Company Profiles
3.1. Abbott Laboratories, Inc.
3.2. Ambry Genetics
3.3. AstraZeneca plc
3.4. bioMeriux SA
3.5. Eli Lilly and Company
3.6. Genoptix, Inc.
3.7. GlaxoSmithKline plc
3.8. Hoffmann-La Roche Ltd.
3.9. Pfizer, Inc.

    Request ToC / Sample Report

    Full Name*

    Company Email*

    Phone Number* [Please add country code]



    Secure Online Payment

    iHealthcareAnalyst, Inc.

    Contact Address

    US Office: 2109, Mckelvey Hill Drive, Maryland Heights, MO 63043, United States
    Phone: +1 (314) 315-4764
    India Office: 5, Shilpa Chambers, Opp. J. M. Road, Shivajinager, Pune 411005, India
    Phone: +91 (20) 25898524
    Email: sales@ihealthcareanalyst.com